ADHD 2023 - Congress Programme

22 SCIENTIFIC PROGRAMME Friday, 19 May 2023 P-03-004 Impact and prevalence of ADHD in indi- viduals with acute psychiatric illness F. Donno, Italy A. Minutolo, L. Reale, F. Palazzo, F. Lenzi, M. Mucci, G. Masi, A. Costantino, S. Carucci, A. Zuddas P-03-005 A qualitative study of stress and work- related mental illness among working adults with ADHD M. Oscarsson, Sweden M. Nelson, A. Rozental, Y. Ginsberg, P. Carlbring, F. Jönsson P-03-006 ADHD siblings with psychosocial adver- sity have a higher risk for psychiatric disorders J. Palacio Ortiz, Colombia M. Martinez, J. Valencia, M. Castaño, L. Palacios, D. Cardona, C. Lopez P-03-007 Nutritional intake and analytical status of children with ADHD and its relation to ADHD symptoms: Preliminary data of a case-control study S. Pinto, Portugal T. Correia-de-Sá, S. Marques, M. Guardiano, C. Vasconcelos, S. Rebelo, P. Moreira, B. Sampaio- Maia, J. Ferreira-Gomes P-03-008 Young, inattentive, and underrepresented: A state-of-the-art review of the role of gender in perceptions ADHD and sugges- tions for improving identification of girls A. Schiros, USA K. Antshel P-03-009 Childhood ADHD problems and mid-life cardiovascular risk: A prospective popula- tion cohort study A. Thapar, United Kingdom L. Riglin, R. Blakey, S. Collishaw, G. Davey- Smith, E. Stergiakouli, K. Tilling, A. Thapar P-03-010 Prevalence and epidemiological charac- teristics of ADHD in pre-school children in Kocaeli, Turkey S. Yavuz Öztürk, Turkey N. Çakın Memik P-04 Guided Poster Tour 14:00–15:30 Onyx Lounge Epidemiology II Chair: S. Dalsgaard, Denmark P-04-001 ADHD prevalence and associated fac- tors among primary school children in Amman, Jordan L. Abbasi, Jordan T. Mazzawi P-04-002 Prevalence of autism spectrum disorder in young people attending ADMiRE, Ireland’s first public specialist service for children with ADHD S. Killeen, Ireland K. Conlan, B. Cawley, M. Grace, J. Keane, J. Colclough, L. Healion, R. Buckmaster, L. O’Rourke, J. McGrath P-04-003 Emergencies of children and adolescents with AD(H)D before and during the SARS- CoV2-19 Pandemic: Is there a change? L. Flik, Germany P. Schneider, M. Pantis, D. Hagmann, K. Allgaier, G. Barth, U. Dürrwächter, A. Conzelmann, T. Renner P-04-004 Organic food consumption during preg- nancy and symptoms of neurodevelop- mental disorders at 8 years of age in the offspring: The Norwegian Mother, Father and Child Cohort Study (MoBa) J. Instanes, Norway B. Skretting Solberg, K. Klungsøyr, L. Grimstvedt Kvalvik, M. Rocio Posserud, J. Haavik P-04-005 Paternal intelligence predicts child grades, but child ADHD independently modifies the link A. Markkula, Sweden K. Igelström, A. Johansson Capusan, P. Gustafsson P-04-006 The impact of Covid-19 on children with ADHD attending public child and youth mental health services in Australia C. Middeldorp, The Netherlands D. Sullivan, L. Payne, K. Stephens, J. Tiego, J. Scott, M. Bellgrove, D. Coghill, E. Sciberras P-04-007 First presentation of ADHD in females over 35: A unique diagnostic challenge K. Naidoo, United Kingdom C. Willis, M. Barsoum, A. Lock P-04-008 Questionnaire survey on long-term school closures and reopening due to COVID-19 in Japan: How did children with ADHD react K. Ono, Japan P-04-009 Emotional and behavioral outcomes among youths with ADHD during Covid lockdown and school closures in England: Results from a large clinical population study using health care record integrated surveys V. Parlatini, United Kingdom L. Frangou, S. Zhang, S. Epstein, A. Morris, L. Zalewski, A. Jewell, S. Velupillai, E. Simonoff, J. Downs

RkJQdWJsaXNoZXIy Mzg2Mjgy